Ovarian Cancer – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of ovarian cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed events of ovarian cancer for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the mature markets and Europe, and 10 years for the other countries we cover.
Ovarian cancer forecast data are available on Clarivate’s Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Clarivate Epidemiology’s ovarian cancer forecast answers the following questions:
- How will changes in the levels of exposure to known risk or protective factors affect the number of people living with a diagnosis of ovarian cancer and the number of new diagnoses of ovarian cancer?
- Of all people diagnosed with ovarian cancer, how many in each country across the major mature pharmaceutical markets are drug-treated?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of ovarian cancer over the forecast period?
In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following ovarian cancer subpopulations:
- Diagnosed ovarian cancer all sites incident cases
- Diagnosed epithelial ovarian cancer incident cases
- Diagnosed fallopian tube cancer incident cases
- Diagnosed primary peritoneal cancer incident cases
- BRCA mutation
- Stage at diagnosis ovarian cancer all sites
- Stage at diagnosis epithelial ovarian cancer
- Stage of diagnosis fallopian tube cancer
- Stage at diagnosis primary peritoneal cancer
- Prevalence ovarian cancer all sites
- Prevalence epithelial ovarian cancer
- Prevalence fallopian tube cancer
- Prevalence primary peritoneal cancer
- Recurrence
- Ovarian cancer drug treatable populations
- Ovarian cancer drug treated and non-drug treated populations
Note: Coverage may vary by country
